|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Expensed transaction costs and mark-to-market adjustments of derivative liabilities | ||
| Issuance of and mark-to-market adjustments of derivative liabilities | ||
| Impairment of assets | ||
| Impairment of product sales inventory | ||
| Depreciation and amortization | ||
| Non-cash vehicle expenses | ||
| Stock-based compensation expense | ||
| Debt discount accretion | ||
| Bad debt expense | ||
| Breakage revenue | ||
| Loss on extinguishment of debt | ||
| Loss on disposal of property and equipment | ||
| Amortization of debt issuance costs and discounts | ||
| Other | ||
| Changes in assets and liabilities, net of impact of business acquisitions and disposals: | ||
| Accounts receivable | ||
| Inventory | ||
| Prepaid expenses and other current assets | ||
| Other assets | ||
| Accounts payable | ||
| Deferred revenue | ||
| Accrued expenses and other current liabilities | ||
| Other liabilities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Purchases of property and equipment | ||
| Purchases of vehicles | ||
| Net cash acquired (used) in acquisitions | ||
| Net cash (used in) provided by investing activities | ||
| Cash flows from financing activities | ||
| Proceeds from Business Combination and PIPE financing | ||
| Transaction costs paid in connection with Business Combination and PIPE financing | ||
| Proceeds from issuance of debt, net of issuance costs | ||
| Proceeds from issuance of convertible debt, net of issuance costs | ||
| Proceeds from issuance of redeemable convertible senior preferred stock and derivatives, net of issuance costs | ||
| Proceeds from issuance of common stock | ||
| Payment for settlement of warrants | ||
| Payment for taxes related to net share settlement | ||
| Debt repayments | ||
| Net cash provided by financing activities | ||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | ||
| Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | ||
| Beginning of period | ||
| End of period | ||
| Non-cash activities: | ||
| Conversion of redeemable convertible preferred stock to common stock in connection with the Business Combination | ||
| Transaction costs not yet paid | ||
| Fair value of net asset acquired in non cash acquisition | ||
| Conversion of convertible debt to redeemable convertible preferred stock in acquisition | ||
| Payment for settlement of debt in exchange for the issuance of common stock under the Purchase Agreement | ||
| Supplemental disclosures of cash flow information | ||
| Interest | ||
| Income taxes | ||
| Proceeds from issuance of redeemable convertible senior preferred stock and derivatives, net of issuance costs | ||
| Cash and cash equivalents | ||
| Restricted cash and cash equivalents |
Loading...
